Joshua Black
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Jumonji Domain-Containing Histone Demethylases | 6 | 2016 | 59 | 1.640 |
Why?
| DNA Replication | 4 | 2020 | 210 | 1.160 |
Why?
| Chromatin | 6 | 2013 | 438 | 0.990 |
Why?
| Lysine | 4 | 2015 | 246 | 0.970 |
Why?
| DNA Copy Number Variations | 2 | 2015 | 158 | 0.960 |
Why?
| Cell Hypoxia | 2 | 2015 | 216 | 0.960 |
Why?
| Histones | 4 | 2019 | 544 | 0.620 |
Why?
| Sequence Analysis, DNA | 1 | 2020 | 741 | 0.590 |
Why?
| MicroRNAs | 4 | 2016 | 627 | 0.580 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2015 | 145 | 0.570 |
Why?
| Chromosomal Proteins, Non-Histone | 4 | 2011 | 102 | 0.540 |
Why?
| Gene Expression Regulation | 2 | 2015 | 2408 | 0.530 |
Why?
| Gene Amplification | 1 | 2016 | 97 | 0.520 |
Why?
| Polycomb Repressive Complex 1 | 1 | 2015 | 51 | 0.510 |
Why?
| Protein Processing, Post-Translational | 3 | 2013 | 408 | 0.480 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 1159 | 0.470 |
Why?
| Methylation | 6 | 2015 | 204 | 0.460 |
Why?
| Transcription, Genetic | 4 | 2011 | 1327 | 0.450 |
Why?
| Chromatin Assembly and Disassembly | 3 | 2013 | 93 | 0.450 |
Why?
| Cell Cycle | 3 | 2015 | 546 | 0.430 |
Why?
| Gene Dosage | 1 | 2013 | 135 | 0.430 |
Why?
| p300-CBP Transcription Factors | 2 | 2008 | 15 | 0.400 |
Why?
| Nervous System Diseases | 1 | 2013 | 254 | 0.350 |
Why?
| Lung Neoplasms | 2 | 2020 | 2222 | 0.350 |
Why?
| Neoplasms | 3 | 2015 | 2151 | 0.350 |
Why?
| Sirtuins | 2 | 2010 | 33 | 0.340 |
Why?
| Histone-Lysine N-Methyltransferase | 3 | 2015 | 99 | 0.320 |
Why?
| Adenosine Triphosphatases | 2 | 2019 | 157 | 0.310 |
Why?
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 232 | 0.300 |
Why?
| CDC2-CDC28 Kinases | 2 | 2016 | 18 | 0.260 |
Why?
| Cell Cycle Proteins | 3 | 2020 | 563 | 0.260 |
Why?
| Cell Line | 4 | 2020 | 2670 | 0.240 |
Why?
| Transcription Factors | 3 | 2013 | 1557 | 0.240 |
Why?
| Breast Neoplasms | 1 | 2016 | 1883 | 0.240 |
Why?
| HeLa Cells | 4 | 2010 | 577 | 0.240 |
Why?
| Humans | 26 | 2020 | 117098 | 0.210 |
Why?
| DNA-Binding Proteins | 2 | 2019 | 1340 | 0.200 |
Why?
| Acetylation | 4 | 2013 | 213 | 0.190 |
Why?
| Drug Resistance, Neoplasm | 2 | 2015 | 669 | 0.180 |
Why?
| Gene Silencing | 2 | 2013 | 176 | 0.180 |
Why?
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 25 | 0.180 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 40 | 0.170 |
Why?
| Viral Nonstructural Proteins | 1 | 2019 | 56 | 0.160 |
Why?
| Molecular Chaperones | 1 | 2020 | 161 | 0.160 |
Why?
| Animals | 11 | 2017 | 32741 | 0.160 |
Why?
| Protein Domains | 1 | 2019 | 212 | 0.150 |
Why?
| Epigenesis, Genetic | 2 | 2020 | 546 | 0.150 |
Why?
| Cholesterol, HDL | 2 | 2015 | 195 | 0.150 |
Why?
| Osteopontin | 1 | 2017 | 37 | 0.140 |
Why?
| Tumor Microenvironment | 1 | 2020 | 451 | 0.140 |
Why?
| Saccharomyces cerevisiae | 1 | 2020 | 491 | 0.140 |
Why?
| ATP Binding Cassette Transporter 1 | 1 | 2015 | 10 | 0.130 |
Why?
| Receptors, LDL | 1 | 2015 | 40 | 0.130 |
Why?
| Immunotherapy | 1 | 2020 | 492 | 0.130 |
Why?
| Histone Demethylases | 2 | 2012 | 28 | 0.130 |
Why?
| Immediate-Early Proteins | 1 | 2015 | 52 | 0.130 |
Why?
| Cells, Cultured | 2 | 2015 | 3956 | 0.130 |
Why?
| TOR Serine-Threonine Kinases | 2 | 2015 | 366 | 0.130 |
Why?
| Trans-Activators | 2 | 2008 | 374 | 0.120 |
Why?
| Open Reading Frames | 1 | 2015 | 114 | 0.120 |
Why?
| Cell Line, Tumor | 3 | 2016 | 2814 | 0.120 |
Why?
| Diet, High-Fat | 1 | 2015 | 247 | 0.120 |
Why?
| Cholesterol, LDL | 1 | 2015 | 317 | 0.120 |
Why?
| Dyslipidemias | 1 | 2015 | 159 | 0.120 |
Why?
| Protein Structure, Tertiary | 2 | 2013 | 818 | 0.110 |
Why?
| ErbB Receptors | 1 | 2017 | 569 | 0.110 |
Why?
| S Phase | 1 | 2013 | 74 | 0.110 |
Why?
| Genomic Instability | 1 | 2013 | 38 | 0.110 |
Why?
| Triglycerides | 1 | 2015 | 500 | 0.110 |
Why?
| Tumor Suppressor Proteins | 1 | 2015 | 286 | 0.110 |
Why?
| Influenza, Human | 1 | 2019 | 551 | 0.110 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2013 | 71 | 0.110 |
Why?
| Binding, Competitive | 2 | 2019 | 201 | 0.110 |
Why?
| Protein Biosynthesis | 1 | 2015 | 389 | 0.110 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2013 | 171 | 0.100 |
Why?
| Protein Kinase Inhibitors | 2 | 2015 | 803 | 0.100 |
Why?
| S-Phase Kinase-Associated Proteins | 1 | 2011 | 18 | 0.100 |
Why?
| F-Box Proteins | 1 | 2011 | 20 | 0.100 |
Why?
| Zebrafish | 1 | 2015 | 419 | 0.100 |
Why?
| HEK293 Cells | 1 | 2013 | 626 | 0.090 |
Why?
| Gene Duplication | 1 | 2011 | 63 | 0.090 |
Why?
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 8 | 0.090 |
Why?
| Caenorhabditis elegans | 2 | 2010 | 286 | 0.090 |
Why?
| Chromatin Immunoprecipitation | 1 | 2010 | 134 | 0.090 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 56 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2015 | 2038 | 0.090 |
Why?
| Sirtuin 1 | 1 | 2010 | 31 | 0.090 |
Why?
| Transcription Factor TFIID | 2 | 2008 | 20 | 0.090 |
Why?
| Homeostasis | 2 | 2015 | 588 | 0.090 |
Why?
| DNA | 2 | 2019 | 1372 | 0.080 |
Why?
| CpG Islands | 1 | 2009 | 123 | 0.080 |
Why?
| Melanoma | 1 | 2015 | 671 | 0.080 |
Why?
| Sirtuin 2 | 1 | 2008 | 13 | 0.080 |
Why?
| Fasting | 1 | 2010 | 251 | 0.080 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 975 | 0.080 |
Why?
| Transfection | 1 | 2010 | 877 | 0.080 |
Why?
| DNA Polymerase II | 1 | 2008 | 37 | 0.080 |
Why?
| Cytoplasm | 1 | 2008 | 269 | 0.080 |
Why?
| Cell Proliferation | 1 | 2015 | 2236 | 0.080 |
Why?
| Down-Regulation | 1 | 2010 | 606 | 0.080 |
Why?
| Crystallography, X-Ray | 2 | 2019 | 414 | 0.080 |
Why?
| Promoter Regions, Genetic | 4 | 2015 | 1141 | 0.070 |
Why?
| Transcriptional Activation | 1 | 2009 | 340 | 0.070 |
Why?
| Flow Cytometry | 1 | 2010 | 1063 | 0.070 |
Why?
| Transcription Factors, General | 1 | 2006 | 5 | 0.070 |
Why?
| Mutation | 2 | 2017 | 3420 | 0.070 |
Why?
| Curcumin | 1 | 2006 | 29 | 0.070 |
Why?
| Histone Acetyltransferases | 1 | 2006 | 53 | 0.070 |
Why?
| Protein Binding | 3 | 2019 | 1949 | 0.070 |
Why?
| Cell Nucleus | 1 | 2008 | 572 | 0.060 |
Why?
| Recombinant Proteins | 1 | 2008 | 1258 | 0.060 |
Why?
| Kinetics | 1 | 2008 | 1583 | 0.060 |
Why?
| Mice, Nude | 2 | 2017 | 653 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2015 | 1941 | 0.060 |
Why?
| Models, Genetic | 1 | 2006 | 587 | 0.060 |
Why?
| Carcinogenesis | 2 | 2015 | 183 | 0.060 |
Why?
| Cholesterol | 2 | 2015 | 371 | 0.050 |
Why?
| Mice | 5 | 2017 | 15311 | 0.050 |
Why?
| Fluorescence Polarization | 1 | 2019 | 35 | 0.040 |
Why?
| RNA, Messenger | 1 | 2006 | 2632 | 0.040 |
Why?
| Catalytic Domain | 1 | 2019 | 205 | 0.040 |
Why?
| Catalysis | 1 | 2019 | 281 | 0.040 |
Why?
| Female | 4 | 2017 | 60672 | 0.040 |
Why?
| A549 Cells | 1 | 2017 | 51 | 0.040 |
Why?
| Enzyme Activation | 1 | 2019 | 793 | 0.040 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2019 | 494 | 0.040 |
Why?
| Heterografts | 1 | 2017 | 124 | 0.030 |
Why?
| Radiation Tolerance | 1 | 2017 | 102 | 0.030 |
Why?
| Apolipoproteins E | 1 | 2015 | 81 | 0.030 |
Why?
| Peptide Initiation Factors | 1 | 2015 | 17 | 0.030 |
Why?
| Mice, Inbred C57BL | 2 | 2015 | 4841 | 0.030 |
Why?
| Hydrazones | 1 | 2015 | 22 | 0.030 |
Why?
| Peptide Chain Initiation, Translational | 1 | 2015 | 38 | 0.030 |
Why?
| Lipoproteins | 1 | 2015 | 164 | 0.030 |
Why?
| Ubiquitination | 1 | 2015 | 86 | 0.030 |
Why?
| Neoplasms, Experimental | 1 | 2015 | 156 | 0.030 |
Why?
| Ribosomal Proteins | 1 | 2015 | 68 | 0.030 |
Why?
| Aminopyridines | 1 | 2015 | 84 | 0.030 |
Why?
| Drug Resistance | 1 | 2015 | 166 | 0.030 |
Why?
| Snail Family Transcription Factors | 1 | 2013 | 20 | 0.030 |
Why?
| Models, Molecular | 1 | 2019 | 1405 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2013 | 72 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2015 | 373 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2013 | 110 | 0.030 |
Why?
| Gene Frequency | 1 | 2015 | 507 | 0.030 |
Why?
| Neoplastic Stem Cells | 1 | 2017 | 335 | 0.030 |
Why?
| Primates | 1 | 2013 | 112 | 0.030 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2013 | 200 | 0.030 |
Why?
| Histone Deacetylases | 1 | 2013 | 197 | 0.030 |
Why?
| Alleles | 1 | 2015 | 816 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2015 | 450 | 0.020 |
Why?
| Cullin Proteins | 1 | 2011 | 12 | 0.020 |
Why?
| Ubiquitin | 1 | 2011 | 65 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 139 | 0.020 |
Why?
| Naphthols | 1 | 2010 | 7 | 0.020 |
Why?
| Heterocyclic Compounds, 4 or More Rings | 1 | 2010 | 16 | 0.020 |
Why?
| Niacinamide | 1 | 2010 | 69 | 0.020 |
Why?
| Protein Stability | 1 | 2010 | 163 | 0.020 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2009 | 17 | 0.020 |
Why?
| Benzamides | 1 | 2010 | 173 | 0.020 |
Why?
| Mice, Knockout | 1 | 2015 | 2648 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2015 | 1314 | 0.020 |
Why?
| Transcription Factor TFIIA | 1 | 2008 | 8 | 0.020 |
Why?
| Epithelial Cells | 1 | 2013 | 940 | 0.020 |
Why?
| Binding Sites | 1 | 2011 | 1206 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 42 | 0.020 |
Why?
| Nucleosomes | 1 | 2009 | 128 | 0.020 |
Why?
| Base Sequence | 1 | 2011 | 2123 | 0.020 |
Why?
| Prognosis | 1 | 2015 | 3391 | 0.020 |
Why?
| Microtubule-Associated Proteins | 1 | 2008 | 183 | 0.020 |
Why?
| Lipids | 1 | 2010 | 584 | 0.020 |
Why?
| Lipopolysaccharides | 1 | 2009 | 825 | 0.020 |
Why?
| Neoplasm Proteins | 1 | 2008 | 396 | 0.020 |
Why?
| Signal Transduction | 1 | 2017 | 4606 | 0.010 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2009 | 977 | 0.010 |
Why?
| Male | 2 | 2017 | 56700 | 0.010 |
Why?
|
|
Black's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|